Showing results (61-70 of 89) with videos related to

Sort By:
Pageof 9
Prenatal Diagnosis|December 1, 1996
Combining inhibin A with existing second-trimester markers in maternal serum screening for Down's syndromeH S Cuckle, S Holding, R Jones, et al.
American Journal of Obstetrics and Gynecology|September 1, 1981
Alpha fetoprotein screening and diagnosis of fetal open neural tube defects: the need for quality controlN J Wald, H S Cuckle, C Catz, et al.
Health Technology Assessment (Winchester, England)|August 10, 2004
Psychosocial aspects of genetic screening of pregnant women and newborns: a systematic reviewJ M Green, J Hewison, H L Bekker, et al.
British Journal of Obstetrics and Gynaecology|March 1, 1981
Raised maternal serum AFP, oligohydramnios and poor fetal outcomeG M Stirrat, J D Gough, S Bullock, et al.
Annals of Clinical Biochemistry|May 1, 1986
Comparison of an ELISA with a RIA method for serum alpha-fetoprotein determination in screening for fetal neural tube defectsR D Barlow, S G Thompson, H S Cuckle, et al.
British Journal of Obstetrics and Gynaecology|November 1, 1991
Second trimester amniotic fluid oestriol, dehydroepiandrosterone sulphate, and human chorionic gonadotrophin levels in Down's syndromeH S Cuckle, N J Wald, J W Densem, et al.
British Journal of Obstetrics and Gynaecology|March 1, 1982
Maternal serum alpha-fetoprotein and low birth weight in relation to gestational ageN J Wald, H S Cuckle, J Boreham, et al.
Obstetrics and Gynecology|February 20, 1998
Weekly nuchal translucency measurements in normal fetusesE Pajkrt, I M de Graaf, B W Mol, et al.
BMJ (Clinical Research Ed.)|August 15, 1992
Antenatal maternal serum screening for Down's syndrome: results of a demonstration projectN J Wald, A Kennard, J W Densem, et al.
Pageof 9